Elsevier, a leading global provider of scientific information and data analytics, has announced an initiative to empower research and development (R&D) across various industries. The company's latest offering, enriched and authoritative scientific Datasets, aims to fuel innovation and support critical decision-making in fields such as life sciences, chemicals, and other research-intensive industries.
The introduction of Elsevier's Datasets provides researchers, data scientists, and industry leaders with a powerful tool to expedite R&D processes and enhance precision across a spectrum of sectors, including life sciences, energy, chemicals and materials, and technology. Use cases for these Datasets encompass a wide range of data science and analytical projects, from disease target identification using natural language processing to predicting molecule efficacy and toxicity through neural networks. Other applications include predictive modeling, Key Opinion Leader (KOL) analysis, and more.
Companies in pharmaceuticals, chemicals, energy, applied materials, and technology can derive valuable scientific insights by integrating Elsevier's data into private, secure computational ecosystems, including custom applications and third-party tools. The Datasets cover various disciplines, with application-ready data available for chemistry, biology, and 22 other fields.
The diverse sources contributing to Elsevier's Datasets include: 19 million full-text articles from peer-reviewed journals; 17 million author profiles; 1.8 billion cited references; 333 million chemical substances and reactions; 86 million bioactivities and biomedical records; and 35 million chemical patents.
Elsevier delivers Datasets flexibly via APIs or flat files, providing accessibility to a wide range of users. The company's team of domain and data science experts is available to support customers' data projects, offering expertise in ontology management, text analytics, and semantic search tools to facilitate the discovery, management, and sharing of data.
With this innovative offering, Elsevier reinforces its commitment to advancing research and development in critical industries, providing a robust platform for scientific inquiry, discovery, and decision-making.
Click here to read the original press release.
